SERUM-LIPIDS IN NORMOLIPIDEMICS AND HYPERLIPIDEMICS AFTER METHYLDOPA AND PROPRANOLOL

被引：20
作者：
DUJOVNE, CA
DECOURSEY, S
KREHBIEL, P
JACKSON, B
CHERNOFF, S
机构：
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1984年 / 36卷 / 02期
关键词：
D O I：
10.1038/clpt.1984.156
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：157 / 162
页数：6
相关论文
共 18 条
[1]  
ALLAIN CC, 1974, CLIN CHEM, V20, P470
[2]   NEGATIVE EFFECTS OF DIURETIC DRUGS ON METABOLIC RISK-FACTORS FOR CORONARY HEART-DISEASE - POSSIBLE ALTERNATIVE DRUG THERAPIES [J].
AMES, RP .
AMERICAN JOURNAL OF CARDIOLOGY, 1983, 51 (04) :632-638
[3]  
BACHORIK PS, 1982, CLIN CHEM, V28, P1375
[4]   PROPRANOLOL AND HYPERTRIGLYCERIDEMIA [J].
BARBORIA.JJ ;
FRIEDBER.HD .
ATHEROSCLEROSIS, 1973, 17 (01) :31-35
[5]  
BUCOLO G, 1973, CLIN CHEM, V19, P476
[6]  
CARLSON LA, 1972, LANCET, V1, P865
[7]  
DUJOVNE CA, 1979, AM J MED SCI, V277, P244
[8]   EFFECT OF L-PROPRANOLOL ON THE BINDING, INTERNALIZATION AND DEGRADATION OF I-125 LOW-DENSITY LIPOPROTEINS BY HUMAN-SKIN FIBROBLASTS [J].
GHISELLI, G ;
BERNINI, F ;
MUSANTI, R ;
FUMAGALLI, R .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1981, 103 (03) :1060-1068
[9]   HIGH-DENSITY LIPOPROTEIN AS A PROTECTIVE FACTOR AGAINST CORONARY HEART-DISEASE - FRAMINGHAM STUDY [J].
GORDON, T ;
CASTELLI, WP ;
HJORTLAND, MC ;
KANNEL, WB ;
DAWBER, TR .
AMERICAN JOURNAL OF MEDICINE, 1977, 62 (05) :707-714
[10]  
GROVE TH, 1979, CLIN CHEM, V25, P560
12